Chemistry, Manufacturing, and Controls Flexibilities for Developing Human Cellular and Gene Therapy Products for a Biologics License Application: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
May 5, 2026
May 5, 2026
739ce951-2fb3-460d-bd26-98a07366db2f
Related Documents
An Acceptable Circular of Information for the Use of Human Blood and Blood Components: Guidance for Industry
Guidance DocumentSeptember 25, 2024Center for Biologics Evaluation and Research
Recognition and Use of a Standard for Uniform Blood and Blood Component Container Labels: Guidance for Industry
Guidance DocumentApril 30, 2024Center for Biologics Evaluation and Research
Regulation of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) - Small Entity Compliance Guide: Guidance for Industry
Guidance DocumentNovember 1, 2022Center for Biologics Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.